Surgical Nivolumab And Ipilimumab For Recurrent GBM
Surgical Nivolumab And Ipilimumab For Recurrent GBM
Active, not recruiting · NCT04606316 · Registry updated 2026-02-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Surgical Nivolumab And Ipilimumab For Recurrent GBM | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Phase 1 | 2026-02-17 | NCT04606316 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bristol-Myers Squibb | 422 |
| Patrick Wen, MD | 1 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dana Farber Cancer Institute | Boston | United States | 133 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| Stanford University | Stanford | United States | 213 |
| University of California Los Angeles | Los Angeles | United States | 87 |